PROKARIUM
Prokarium is a biopharmaceutical company leading the oncology field of microbial immunotherapy The Company’s pipeline is designed to unlock a new generation of immuno-oncology therapeutics by re engineering evolution into a synthetic biology platform Prokarium’s lead program is focused on transforming the treatment paradigm in bladder cancer by orchestrating immune driven, long lasting antitumor effects
PROKARIUM
Social Links:
Industry:
Biotechnology Genetics Health Care Oncology Pharmaceutical
Founded:
2012-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.prokarium.com
Total Employee:
11+
Status:
Active
Total Funding:
78.43 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon WordPress Google Maps Person Schema Gravatar Profiles Digital Ocean RankMath
Similar Organizations
Arctic Therapeutics
Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.
BlossomHill Therapeutics
BlossomHill Therapeutics, Inc. is a biopharmaceutical company focusing on oncology and autoimmune disorders.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Pharmacenter
Pharmacenter is a company that provides services in the area of oncology, urology, and hospital injectables.
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Current Advisors List
Current Employees Featured
Founder
Investors List
The Future Fund
The Future Fund investment in Series B - Prokarium
Riyadh Valley Company
Riyadh Valley Company investment in Series B - Prokarium
Korea Investment Partners
Korea Investment Partners investment in Series B - Prokarium
Flerie Invest
Flerie Invest investment in Series B - Prokarium
Wellcome Trust
Wellcome Trust investment in Grant - Prokarium
Flerie Invest
Flerie Invest investment in Series A - Prokarium
Korea Investment Partners
Korea Investment Partners investment in Series A - Prokarium
Riyadh Valley Company
Riyadh Valley Company investment in Series A - Prokarium
SynbiCITE
SynbiCITE investment in Grant - Prokarium
Innovate UK
Innovate UK investment in Grant - Prokarium
Key Employee Changes
Official Site Inspections
http://www.prokarium.com Semrush global rank: 4.02 M Semrush visits lastest month: 2.68 K
- Host name: node205eu.cloudwebhostingeu.com
- IP address: 89.34.18.57
- Location: Netherlands
- Latitude: 52.3824
- Longitude: 4.8995
- Timezone: Europe/Amsterdam
More informations about "Prokarium"
Prokarium - Crunchbase Company Profile & Funding
Prokarium is a biopharmaceutical company leading the oncology field of microbial immunotherapy The Company’s pipeline is designed to unlock a new generation of immuno-oncology therapeutics by re engineering evolution into a synthetic …See details»
Org Chart Prokarium - The Official Board
Organizational Chart of Prokarium. Prokarium www.prokarium.com. has 14 executives +44 781 235 3060; Add an executive. Prokarium News . Anything missing? We search for you. Print or …See details»
Prokarium Company Profile 2024: Valuation, Funding & Investors
Prokarium was founded in 2012. Where is Prokarium headquartered? Prokarium is headquartered in London, United Kingdom. What is the size of Prokarium? Prokarium has 22 total employees. …See details»
Prokarium Ltd - VentureRadar
Prokarium is investigating the use of engineered bacteria for the development of microbial immunotherapy for solid tumours. Their first oncology indication in preclinical development is …See details»
Member profile: Prokarium Ltd | BIA
Prokarium’s Vaxonella platform enables almost any protein vaccine to be delivered to and produced from within the body’s own immune cells. About Prokarium Ltd Prokarium's vision is …See details»
Prokarium - Overview, News & Similar companies | ZoomInfo.com
Nov 2, 2023 Who is Prokarium. Prokarium is a biopharmaceutical company pioneering the field of microbial immunotherapy. Our pipeline is designed to unlock the next level of immu no …See details»
Prokarium - LinkedIn
Prokarium is pioneering the field of microbial immunotherapy. Our pipeline is designed to unlock the next level of immuno-oncology by building on the most recent advances in cancer …See details»
Prokarium - Funding, Financials, Valuation & Investors - Crunchbase
Prokarium is biopharmaceutical company leading the oncology field of microbial immunotherapy. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. ... How much …See details»
Prokarium - Golden
Prokarium is a biopharmaceutical company focused on developing vaccination and cancer immunotherapy solutions based on synthetic biology. Overview Structured Data Issues …See details»
Prokarium Company Profile - Office Locations, Competitors, …
Prokarium is a company that develops a microbial genetics product designed for targeted vaccines and cancer immunotherapies. The company's product generates broad immune …See details»
Prokarium - Contacts, Employees, Board Members, Advisors
Organization. Prokarium . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. Number of Board …See details»
Prokarium Announces $30 Million Financing to Deliver Lead …
Feb 9, 2023 Prokarium’s pipeline leverages evolutionary advantages of a proprietary strain of Salmonella and combines them with bespoke synthetic circuits to deliver diverse therapeutic …See details»
Prokarium Appoints Kristen Albright as Chief Executive Officer
LONDON, UK – July 27, 2021 – Prokarium, a biopharmaceutical company pioneering the oncology field of microbial immunotherapy, today announced the appointment of Kristen …See details»
Prokarium and Wacker Biotech Sign Manufacturing Contract for …
Prokarium, a biopharmaceutical company pioneering the oncology field of microbial immunotherapy, and Wacker Biotech announced today that they had signed a contract for the …See details»
Team - Prokarium
Jan 9, 2023 London, UK – February 7, 2024 – Prokarium, a clinical-stage biopharmaceutical company bioengineering Living Cures through cutting-edge synthetic... Read more. February …See details»
Prokarium's CEO explains how the company is harnessing
Apr 29, 2024 Prokarium's CEO explains how the company is harnessing bacteria as a therapy, and in the future as a deliverer of therapies Kristen Albright describes Prokarium's bladder …See details»
Prokarium Announces $30 Million Financing to Deliver Lead …
Feb 9, 2023 Prokarium’s lead program has the potential to transform the treatment paradigm in bladder cancer, one of the costliest cancers to treat, in its efforts to become the new standard …See details»
Prokarium and Ginkgo Bioworks Announce Partnership to …
Jan 9, 2023 Ginkgo is excited to bolster its work with leading companies like Prokarium, which can utilize Ginkgo’s services to innovate and expand what is possible with novel therapeutics.” …See details»
Prokarium Expands R&D Capabilities with London Biofoundry to …
Jan 26, 2022 Prokarium is a biopharmaceutical company pioneering the field of microbial immunotherapy. Our pipeline is designed to unlock the next level of immuno-oncology by …See details»